Scientists test second round of radiation for deadly brain cancer
NCT ID NCT02709226
Summary
This study tested the safety of giving a second course of radiation to people whose aggressive brain tumor (glioblastoma) had grown back after initial treatment. The main goal was to find the highest dose of repeat radiation that patients could tolerate without severe side effects. Seventeen adults who had been treated with radiation over a year prior participated, receiving daily treatments for 2-3 weeks.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOSARCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
Conditions
Explore the condition pages connected to this study.